Corrigendum

Area of Science:

• Vascular Medicine
• Phlebology
• Medical Device Technology

Background:

• Varicose veins are a common vascular condition impacting patient quality of life.
• Polidocanol endovenous microfoam is a treatment option for superficial venous abnormalities.
• Previous studies have investigated patient-reported outcomes following this treatment.

Purpose of the Study:

• To issue a formal correction to a previously published study.
• To ensure accuracy in reporting patient-reported outcomes after polidocanol endovenous microfoam treatment.
• To provide updated details on conflicts of interest and funding statements.

Main Methods:

• Correction of typographical errors in the original publication.
• Replacement of specific trademarked terms (VVSymQ® to VVSymQ™).
• Addition of supplementary information regarding financial disclosures and support.

Main Results:

• The core findings regarding patient-reported outcomes remain consistent.
• The correction enhances the precision of the study's terminology.
• Updated disclosures provide greater transparency on potential conflicts.

Conclusions:

• The corrected version maintains the integrity of the original research.
• Accurate reporting is crucial for scientific reproducibility and reader trust.
• The study continues to support the efficacy of polidocanol endovenous microfoam in improving patient outcomes for varicose veins.